Lensar (LNSR) Research & Development (2019 - 2026)
Lensar's (LNSR) quarterly Research & Development came in at $1.3 million in Q2 2026, down 10.67% year-over-year from $1.4 million in Q2 2025, and down 8.09% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
Lensar (LNSR) Research & Development (2019 - 2026) Analysis & Trends
Lensar (LNSR) has reported Research & Development for 8 consecutive years, with $1.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Research & Development fell 10.67% year-over-year to $1.3 million in Q2 2026; TTM through Jun 2026 was $5.3 million, a 3.18% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, up 5.5% from the prior year.
- Research & Development was $1.3 million for Q2 2026 at Lensar, down from $1.4 million in the prior quarter.
- Over five years, Research & Development peaked at $4.8 million in Q1 2022 and troughed at $1.2 million in Q3 2024.
- A 5-year average of $1.8 million and a median of $1.5 million in 2023 frame the typical range for Research & Development.
- Across the five-year window, Research & Development soared 74.36% in 2022 and slumped 65.54% in 2023, its largest moves.
- Over 5 years, Research & Development stood at $1.6 million in 2022, then decreased by 9.41% to $1.5 million in 2023, then declined by 8.75% to $1.3 million in 2024, then dropped by 2.92% to $1.3 million in 2025, then declined by 1.77% to $1.3 million in 2026.
- The last three Research & Development figures came in at $1.3 million (Q2 2026), $1.4 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.42 Bn | 178.82 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 124.16 Bn | 118.94 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 118.41 Bn | 109.59 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 104.45 Bn | 100.98 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 66.47 Bn | 65.93 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.46 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Alcon | 33.95 Bn | 32.50 Bn | 1.68 Bn | -663.00 Mn |
| 8 | Dexcom | 32.24 Bn | 30.29 Bn | 830.00 Mn | 153.00 Mn |
| 9 | Steris | 21.17 Bn | 20.68 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Lensar | 103.29 Mn | 89.73 Mn | 9.78 Mn | 1.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.30 Mn |
| Sep 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.43 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 1.34 Mn |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.53 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | 1.58 Mn |
| Jun 30, 2022 | 3.83 Mn |
| Mar 31, 2022 | 4.79 Mn |
| Dec 31, 2021 | 3.42 Mn |
| Sep 30, 2021 | 3.18 Mn |